2023 to 2024 seasonal influenza vaccine effective for reducing risk
Feb 29, 2024
Vaccine effectiveness against influenza-linked outpatient visits ranged from 33 to 49%, and against hospitalization it ranged from 41 to 44% among adults.
Third mRNA COVID-19 vaccine dose appears to be safe
Apr 15, 2022
There were higher reports of low-severity adverse effects but no change in severe events.
Bivalent mRNA-1273.214 elicits better response against omicron
Sep 27, 2022
A booster dose of mRNA-1273.214 elicits more neutralizing antibodies against omicron compared with mRNA-1273, the original Moderna vaccine, with no new safety concerns.
Nobel Prize for medicine awarded to COVID-19 vaccine pioneers
Oct 02, 2023
The prize panel said that their discovery ‘fundamentally changed our understanding of how mRNA interacts with our immune system.’
Allergy history may up risk for reactions to mRNA COVID-19 vaccine
Nov 04, 2021
The risk for allergic reactions within three days of vaccination is higher for those with history of high-risk allergy, but most completed the two-dose regimen. The mRNA vaccines approved for use against...
mRNA COVID-19 vaccine effectiveness lower during delta strain era
Aug 20, 2021
Adjusted effectiveness was 53.1% against infection in nursing home residents during the period when delta strain was predominant.
Cardiac complications up after SARS-CoV-2 infection versus vaccines
Apr 06, 2022
“[T]he risks for these complications were higher after infection than after vaccination among males and females in all age groups,” the authors write.
Allergic reactions to mRNA COVID-19 vaccines characterized
Sep 20, 2021
20 of 22 patients with suspected allergic reactions were women; 17 met Brighton anaphylaxis criteria.
Fourth COVID-19 shot beneficial in patients with autoimmune rheumatic diseases
Nov 28, 2023
A fourth dose reduces the risk for SARS-CoV-2 for patients with systemic autoimmune rheumatic diseases using DMARDs.
FDA authorizes Pfizer, Moderna COVID-19 vaccine boosters for all adults
By
Lois A. Bowers
Nov 19, 2021
The U.S. Food and Drug Administration on Friday amended the emergency use authorizations for both the Pfizer-BioNTech and Moderna COVID-19 vaccines, authorizing use of a single booster dose for everyone...